Abnormal coagulation profile in people living with HIV-AIDS on combined Antiretroviral Therapy: findings from a case-control study in the Ho municipality, Ghana

INTRODUCTION: Although combined Anti-Retroviral Therapy (cART) has improved the quality of life and survival in people living with HIV-AIDS (PLWHA), there have been reports of increased non-AIDS related co-morbidities such as coagulopathies. The objective of this study was to assess the effect of cA...

Full description

Bibliographic Details
Main Authors: Richard Kobina Dadzie Ephraim, James Elikem Ahadzie, Patrick Adu, Joseph Boachie, Hope Agbodzakey, Prince Adoba, Obed Cudjoe
Format: Article
Language:English
Published: The Pan African Medical Journal 2018-02-01
Series:The Pan African Medical Journal
Subjects:
Online Access: https://www.panafrican-med-journal.com/content/article/29/121/pdf/121.pdf
_version_ 1818916746927538176
author Richard Kobina Dadzie Ephraim
James Elikem Ahadzie
Patrick Adu
Joseph Boachie
Hope Agbodzakey
Prince Adoba
Obed Cudjoe
author_facet Richard Kobina Dadzie Ephraim
James Elikem Ahadzie
Patrick Adu
Joseph Boachie
Hope Agbodzakey
Prince Adoba
Obed Cudjoe
author_sort Richard Kobina Dadzie Ephraim
collection DOAJ
description INTRODUCTION: Although combined Anti-Retroviral Therapy (cART) has improved the quality of life and survival in people living with HIV-AIDS (PLWHA), there have been reports of increased non-AIDS related co-morbidities such as coagulopathies. The objective of this study was to assess the effect of cART on the coagulation profile of PLWHA. METHODS: this case-control study recruited 110 PLWHA (65 patients on cART, and 45 cART naïve patients) from the antiretroviral therapy unit of Volta Regional Hospital, Ho. Blood was collected for prothrombin time (PT), activated partial thromboplastin time (APTT)and platelet count. RESULTS: cART naïve individuals had a high PT (p =0.001; 17.2 vs 13.8) and APTT (p = 0.081; 59.7 vs 55.3) compared to their counterparts on cART. Also, INR was significantly lower in cART-treated PLWHA (p=0.001). Platelet count was high in participants on therapy compared to their naïve counterparts (204.7 vs 193.6, p = 0.402). Patients on zidovudine + nevirapin + efavirenz therapy had a significantly lower PT compared to those on zidovudine + lamivudine + efavirenz therapy {p = 0.02, 13.23 vs 14.66}. Additionally, PLWHA on zidovudine + nevirapin + efavirenz had reduced APTT compared to those on zidovudine + lamivudine + efavirenz therapy, or zidovudine + lamivudine+ nevirapine therapy (p = 0.058; 47.55 vs 56.81 vs 56.85 respectively). CONCLUSION: HIV infection adversely affects the coagulation profile in PLWHA which improves with cART. Barring the existence of other comorbidities, cART with zidovudine + nevirapin + efavirenz combination could be the treatment of choice as it significantly improves the coagulation profile in PLWHA.
first_indexed 2024-12-20T00:23:05Z
format Article
id doaj.art-6756845fa7914cb7a81395eff3c1c31f
institution Directory Open Access Journal
issn 1937-8688
1937-8688
language English
last_indexed 2024-12-20T00:23:05Z
publishDate 2018-02-01
publisher The Pan African Medical Journal
record_format Article
series The Pan African Medical Journal
spelling doaj.art-6756845fa7914cb7a81395eff3c1c31f2022-12-21T20:00:08ZengThe Pan African Medical JournalThe Pan African Medical Journal1937-86881937-86882018-02-012912110.11604/pamj.2018.29.121.78117811Abnormal coagulation profile in people living with HIV-AIDS on combined Antiretroviral Therapy: findings from a case-control study in the Ho municipality, GhanaRichard Kobina Dadzie Ephraim0James Elikem Ahadzie1Patrick Adu2Joseph Boachie3Hope Agbodzakey4Prince Adoba5Obed Cudjoe6 Department of Medical Laboratory Technology, School of Allied Health Sciences, College of Health and Allied Sciences (COHAS), University of Cape Coast, Ghana Department of Medical Laboratory Technology, School of Allied Health Sciences, College of Health and Allied Sciences (COHAS), University of Cape Coast, Ghana Department of Medical Laboratory Technology, School of Allied Health Sciences, College of Health and Allied Sciences (COHAS), University of Cape Coast, Ghana Department of Medical Laboratory Technology, School of Allied Health Sciences, College of Health and Allied Sciences (COHAS), University of Cape Coast, Ghana Department of Medical Laboratory Technology, School of Allied Health Sciences, College of Health and Allied Sciences (COHAS), University of Cape Coast, Ghana Department of Medical Laboratory Technology, School of Allied Health Sciences, College of Health and Allied Sciences (COHAS), University of Cape Coast, Ghana Department of Medical Laboratory Technology, School of Allied Health Sciences, College of Health and Allied Sciences (COHAS), University of Cape Coast, Ghana INTRODUCTION: Although combined Anti-Retroviral Therapy (cART) has improved the quality of life and survival in people living with HIV-AIDS (PLWHA), there have been reports of increased non-AIDS related co-morbidities such as coagulopathies. The objective of this study was to assess the effect of cART on the coagulation profile of PLWHA. METHODS: this case-control study recruited 110 PLWHA (65 patients on cART, and 45 cART naïve patients) from the antiretroviral therapy unit of Volta Regional Hospital, Ho. Blood was collected for prothrombin time (PT), activated partial thromboplastin time (APTT)and platelet count. RESULTS: cART naïve individuals had a high PT (p =0.001; 17.2 vs 13.8) and APTT (p = 0.081; 59.7 vs 55.3) compared to their counterparts on cART. Also, INR was significantly lower in cART-treated PLWHA (p=0.001). Platelet count was high in participants on therapy compared to their naïve counterparts (204.7 vs 193.6, p = 0.402). Patients on zidovudine + nevirapin + efavirenz therapy had a significantly lower PT compared to those on zidovudine + lamivudine + efavirenz therapy {p = 0.02, 13.23 vs 14.66}. Additionally, PLWHA on zidovudine + nevirapin + efavirenz had reduced APTT compared to those on zidovudine + lamivudine + efavirenz therapy, or zidovudine + lamivudine+ nevirapine therapy (p = 0.058; 47.55 vs 56.81 vs 56.85 respectively). CONCLUSION: HIV infection adversely affects the coagulation profile in PLWHA which improves with cART. Barring the existence of other comorbidities, cART with zidovudine + nevirapin + efavirenz combination could be the treatment of choice as it significantly improves the coagulation profile in PLWHA. https://www.panafrican-med-journal.com/content/article/29/121/pdf/121.pdf apttptcartinrhiv/aidszidovudineefavirenzlamivudinenevirapine
spellingShingle Richard Kobina Dadzie Ephraim
James Elikem Ahadzie
Patrick Adu
Joseph Boachie
Hope Agbodzakey
Prince Adoba
Obed Cudjoe
Abnormal coagulation profile in people living with HIV-AIDS on combined Antiretroviral Therapy: findings from a case-control study in the Ho municipality, Ghana
The Pan African Medical Journal
aptt
pt
cart
inr
hiv/aids
zidovudine
efavirenz
lamivudine
nevirapine
title Abnormal coagulation profile in people living with HIV-AIDS on combined Antiretroviral Therapy: findings from a case-control study in the Ho municipality, Ghana
title_full Abnormal coagulation profile in people living with HIV-AIDS on combined Antiretroviral Therapy: findings from a case-control study in the Ho municipality, Ghana
title_fullStr Abnormal coagulation profile in people living with HIV-AIDS on combined Antiretroviral Therapy: findings from a case-control study in the Ho municipality, Ghana
title_full_unstemmed Abnormal coagulation profile in people living with HIV-AIDS on combined Antiretroviral Therapy: findings from a case-control study in the Ho municipality, Ghana
title_short Abnormal coagulation profile in people living with HIV-AIDS on combined Antiretroviral Therapy: findings from a case-control study in the Ho municipality, Ghana
title_sort abnormal coagulation profile in people living with hiv aids on combined antiretroviral therapy findings from a case control study in the ho municipality ghana
topic aptt
pt
cart
inr
hiv/aids
zidovudine
efavirenz
lamivudine
nevirapine
url https://www.panafrican-med-journal.com/content/article/29/121/pdf/121.pdf
work_keys_str_mv AT richardkobinadadzieephraim abnormalcoagulationprofileinpeoplelivingwithhivaidsoncombinedantiretroviraltherapyfindingsfromacasecontrolstudyinthehomunicipalityghana
AT jameselikemahadzie abnormalcoagulationprofileinpeoplelivingwithhivaidsoncombinedantiretroviraltherapyfindingsfromacasecontrolstudyinthehomunicipalityghana
AT patrickadu abnormalcoagulationprofileinpeoplelivingwithhivaidsoncombinedantiretroviraltherapyfindingsfromacasecontrolstudyinthehomunicipalityghana
AT josephboachie abnormalcoagulationprofileinpeoplelivingwithhivaidsoncombinedantiretroviraltherapyfindingsfromacasecontrolstudyinthehomunicipalityghana
AT hopeagbodzakey abnormalcoagulationprofileinpeoplelivingwithhivaidsoncombinedantiretroviraltherapyfindingsfromacasecontrolstudyinthehomunicipalityghana
AT princeadoba abnormalcoagulationprofileinpeoplelivingwithhivaidsoncombinedantiretroviraltherapyfindingsfromacasecontrolstudyinthehomunicipalityghana
AT obedcudjoe abnormalcoagulationprofileinpeoplelivingwithhivaidsoncombinedantiretroviraltherapyfindingsfromacasecontrolstudyinthehomunicipalityghana